BioNTech SE (BNTX) vs Moderna, Inc. (MRNA)
A side-by-side comparison of BioNTech SE and Moderna, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 28, 2026. Differences are shown without an overall score or investment verdict.
BNTX
BioNTech SE
$92.45HealthcareDelayed quote: Jul 28, 2026, 4:00 PM EDT
MRNA
Moderna, Inc.
$55.81HealthcareDelayed quote: Jul 28, 2026, 4:00 PM EDT
Total return — BNTX vs MRNA
growth of $100 · dividends reinvested · last 7yBNTX +548.2%MRNA +291.8%BNTX compounded faster
BNTX MRNA
BNTX vs MRNA: by the numbers
- •BNTX is the larger company ($23.38B vs $22.14B market cap).
- •Both run net losses; BNTX's is the smaller (-44.73% vs -143.55% net margin).
- •MRNA grew revenue faster over the past five years (19.33% vs 2.16% CAGR).
Metrics side by side
Valuation
| Metric | BNTX | MRNA |
|---|---|---|
| P/S ratio | 7.01 | 9.88 |
| P/B ratio | 1.07 | 2.97 |
| FCF yield | 6.49% | N/A |
Profitability
| Metric | BNTX | MRNA |
|---|---|---|
| Gross margin | 73.26% | 55.35% |
| Operating margin | -22.63% | -153.35% |
| Net margin | -44.73% | -143.55% |
| ROE | -6.79% | -43.12% |
| ROIC | -3.14% | -29.70% |
Growth (annualized)
| Metric | BNTX | MRNA |
|---|---|---|
| Revenue CAGR (5Y) | 2.16% | 19.33% |
| Total return CAGR (5Y) | -20.13% | -31.25% |
Frequently asked
- Which has grown faster, BNTX or MRNA?
- Over the past five years, MRNA grew revenue faster — BNTX at a 2.16% CAGR versus MRNA at 19.33%.
- How have BNTX and MRNA total returns compared?
- Over the past 5 years, BNTX delivered -20.13% and MRNA delivered -31.25% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
BioNTech SE P/E ratioModerna P/E ratioBioNTech SE dividend yieldModerna dividend yieldBioNTech SE ROEModerna ROEBioNTech SE operating marginModerna operating marginBioNTech SE revenue growthModerna revenue growthBioNTech SE free cash flowModerna free cash flow
BioNTech SE & Moderna appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 28, 2026.